Pay in 4 interest-free payments of $6.65 Learn more
Ships within 48 hours · Estimated delivery Sep 23 - Sep 28
doi: 10.1007/s11657-022-01061-5 4 BouyerBLeroyFRudantJWeillACosteJ
It is used as an acute treatment in patients with severe generalized MG and MuSK-MG, as a maintenance therapy in patients with refractory and juvenile MG, and in myasthenia crises [1]
Overall agreement 55%: A+ 25%, A 30%, A 15%, D 10%, D 20%, D+ 0%
Why Is the FDA Making This Change
They may: Perform detailed neurological examinations Assess memory and cognitive function Recommend MRI or CT scans when appropriate Order nerve-related blood tests Identify conditions such as multiple sclerosis, epilepsy, Parkinsons disease, or dementia Refer patients for neuropsychological testing If no neurological disease is found, the neurologist may recommend seeing specialists such as endocrinologists, psychiatrists, sleep physicians, or psychologists
US$ 23.88
US$ 24.35
US$ 24.59
US$ 25.13
US$ 28.57
